BioCentury | Jun 26, 2019
Product Development

AbbVie chooses revenue over innovation with Allergan takeout

...at least three products could threaten that position. FDA approved competing product Jeuveau prabotulinumtoxinA from Evolus Inc....
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Evolus Inc....
BioCentury | Apr 26, 2019
Company News

European regulatory roundup: CHMP opinions and a Portola approval

...Doptelet is an oral CD110 agonist. Dova climbed $0.84 to $9.36 Friday. Nuceiva prabotulinumtoxinA from Evolus Inc....
...under age 65 when the severity of the facial lines has an important psychological impact. Evolus...
...an injectable 900 kiloDalton (kDa) botulinum toxin type A complex, as Jeuveau in the U.S. Evolus...
BioCentury | Apr 11, 2019
Politics & Policy

Regulatory reprieve with Brexit delay

...Friday. At least seven companies are awaiting a CHMP opinion or EC action this quarter: Evolus Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...epithelioid sarcoma Submit NDA 2Q19 Evofem Biosciences Inc. (NASDAQ:EVFM) Amphora Prevent pregnancy Resubmit NDA 2Q19 Evolus Inc....
BioCentury | Apr 6, 2019
Finance

Everybody up

...testosterone undecanoate for testosterone replacement therapy in adult males for primary hypogonadism and hypogonadotropic hypogonadism Evolus...
BioCentury | Jan 17, 2019
Regulation

Products on shutdown standby

...of major depressive disorder (MDD) in patients with an inadequate response to antidepressants 1/31/19 Standard Evolus Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Inc. (NASDAQ:EVOK) Gimoti (EVK-001) Acute and recurrent diabetic gastroparesis in adult women PDUFA date 4/1/19 Evolus Inc....
BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...regulatory and quality at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint...
BioCentury | Jul 13, 2018
Finance

Pause for politics

...$30.5 $141.6 $247.1 75% Korea Arlico Pharm Co. Ltd. (KOSDAQ:260660) 2/12/18 $26.0 $97.8 $115.4 18% Evolus Inc....
BioCentury | Jun 30, 2018
Finance

Hidden in the rough

...Herzuma trastuzumab (CT-P6), a biosimilar of Herceptin, and Truxima rituximab (CT-P10), a biosimilar of Rituxan Evolus Inc....
Items per page:
1 - 10 of 26
BioCentury | Jun 26, 2019
Product Development

AbbVie chooses revenue over innovation with Allergan takeout

...at least three products could threaten that position. FDA approved competing product Jeuveau prabotulinumtoxinA from Evolus Inc....
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Evolus Inc....
BioCentury | Apr 26, 2019
Company News

European regulatory roundup: CHMP opinions and a Portola approval

...Doptelet is an oral CD110 agonist. Dova climbed $0.84 to $9.36 Friday. Nuceiva prabotulinumtoxinA from Evolus Inc....
...under age 65 when the severity of the facial lines has an important psychological impact. Evolus...
...an injectable 900 kiloDalton (kDa) botulinum toxin type A complex, as Jeuveau in the U.S. Evolus...
BioCentury | Apr 11, 2019
Politics & Policy

Regulatory reprieve with Brexit delay

...Friday. At least seven companies are awaiting a CHMP opinion or EC action this quarter: Evolus Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...epithelioid sarcoma Submit NDA 2Q19 Evofem Biosciences Inc. (NASDAQ:EVFM) Amphora Prevent pregnancy Resubmit NDA 2Q19 Evolus Inc....
BioCentury | Apr 6, 2019
Finance

Everybody up

...testosterone undecanoate for testosterone replacement therapy in adult males for primary hypogonadism and hypogonadotropic hypogonadism Evolus...
BioCentury | Jan 17, 2019
Regulation

Products on shutdown standby

...of major depressive disorder (MDD) in patients with an inadequate response to antidepressants 1/31/19 Standard Evolus Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Inc. (NASDAQ:EVOK) Gimoti (EVK-001) Acute and recurrent diabetic gastroparesis in adult women PDUFA date 4/1/19 Evolus Inc....
BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...regulatory and quality at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint...
BioCentury | Jul 13, 2018
Finance

Pause for politics

...$30.5 $141.6 $247.1 75% Korea Arlico Pharm Co. Ltd. (KOSDAQ:260660) 2/12/18 $26.0 $97.8 $115.4 18% Evolus Inc....
BioCentury | Jun 30, 2018
Finance

Hidden in the rough

...Herzuma trastuzumab (CT-P6), a biosimilar of Herceptin, and Truxima rituximab (CT-P10), a biosimilar of Rituxan Evolus Inc....
Items per page:
1 - 10 of 26